Comparative Effects of Ciprofol and Propofol on Pain Intensity on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study

Sponsor
Guangdong Second Provincial General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06020469
Collaborator
(none)
6,500
1
2
3243.3

Study Details

Study Description

Brief Summary

Data intelligence platform was widely used to facilitate the process of clinical research. However, a platform that integrates natural language processing (NLP) and machine learning (ML) algorithms has not been reported in perioperative medical management.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    6500 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Comparative Effects of Ciprofol and Propofol on Pain Intensity of the Patients Without PCA on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study
    Anticipated Study Start Date :
    Oct 1, 2023
    Anticipated Primary Completion Date :
    Oct 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Numeric Rating Scale (NRS) score after surgery <4

    Numeric Rating Scale (NRS) score after surgery ≥ 4

    Outcome Measures

    Primary Outcome Measures

    1. Area under the curve [October 2022 to October 2023]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients were included if they were above 18 years old, undergoing non-local anesthesia surgery.
    Exclusion Criteria:
    • The basic information such gender, age, height, weight, and body mass index (BMI) were missing.

    • Patients undergoing day surgery, with a history of multiple operations, or entering ICU after surgery, and losing the NRS score during movement at 24h after surgery.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Guangdong Second Provincial General Hospital Guangzhou Guangdong China

    Sponsors and Collaborators

    • Guangdong Second Provincial General Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hui Zhang, associate chief physician, Guangdong Second Provincial General Hospital
    ClinicalTrials.gov Identifier:
    NCT06020469
    Other Study ID Numbers:
    • GD2HMZK
    First Posted:
    Aug 31, 2023
    Last Update Posted:
    Aug 31, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hui Zhang, associate chief physician, Guangdong Second Provincial General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 31, 2023